Literature DB >> 12706748

Leishmania mexicana: promastigotes migrate through osmotic gradients.

Graham Leslie1, Michael Barrett, Richard Burchmore.   

Abstract

During the insect phase of the parasite lifecycle, Leishmania promastigotes move from the midgut to the anterior regions of the alimentary tract of their sandfly vector. Chemotaxis of Leishmania promastigotes towards sugars has been reported, and the putative presence of sugar gradient in the insect foregut has been suggested to play a role in promastigote development in the insect. We have further investigated the potential of Leishmania mexicana promastigotes to respond to chemical stimulii. We find that promastigotes move towards concentrations of all substances tested and that this taxis requires the presence of an osmotic gradient. Our results indicate that behaviour that has previously been interpreted as chemotaxis is better understood as osmotaxis. The implications of this observation are discussed in the context of promastigote development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12706748     DOI: 10.1016/s0014-4894(03)00031-6

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  14 in total

1.  Analysis of ESTs from Lutzomyia longipalpis sand flies and their contribution toward understanding the insect-parasite relationship.

Authors:  Rod J Dillon; Al C Ivens; Carol Churcher; Nancy Holroyd; Michael A Quail; Matthew E Rogers; M Bento Soares; Maria F Bonaldo; Thomas L Casavant; Mike J Lehane; Paul A Bates
Journal:  Genomics       Date:  2006-08-01       Impact factor: 5.736

2.  Leishmania mexicana amazonensis: plasma membrane adenine nucleotide translocator and chemotaxis.

Authors:  S Detke; R Elsabrouty
Journal:  Exp Parasitol       Date:  2007-10-22       Impact factor: 2.011

Review 3.  Touching the Surface: Diverse Roles for the Flagellar Membrane in Kinetoplastid Parasites.

Authors:  Felice D Kelly; Marco A Sanchez; Scott M Landfear
Journal:  Microbiol Mol Biol Rev       Date:  2020-04-01       Impact factor: 11.056

4.  Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows that TOR3 is required for acidocalcisome biogenesis and animal infectivity.

Authors:  Luciana Madeira da Silva; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-15       Impact factor: 11.205

5.  Alteration in glycerol and metalloid permeability by a single mutation in the extracellular C-loop of Leishmania major aquaglyceroporin LmAQP1.

Authors:  Nestor L Uzcategui; Yao Zhou; Katherine Figarella; Jun Ye; Rita Mukhopadhyay; Hiranmoy Bhattacharjee
Journal:  Mol Microbiol       Date:  2008-10-22       Impact factor: 3.501

6.  The Leishmania major BBSome subunit BBS1 is essential for parasite virulence in the mammalian host.

Authors:  Helen P Price; Daniel Paape; Michael R Hodgkinson; Katie Farrant; Johannes Doehl; Meg Stark; Deborah F Smith
Journal:  Mol Microbiol       Date:  2013-09-17       Impact factor: 3.501

7.  Reactivation of flagellar motility in demembranated Leishmania reveals role of cAMP in flagellar wave reversal to ciliary waveform.

Authors:  Aakash Gautam Mukhopadhyay; Chinmoy Sankar Dey
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

8.  Leishmania HASP and SHERP Genes Are Required for In Vivo Differentiation, Parasite Transmission and Virulence Attenuation in the Host.

Authors:  Johannes S P Doehl; Jovana Sádlová; Hamide Aslan; Kateřina Pružinová; Sonia Metangmo; Jan Votýpka; Shaden Kamhawi; Petr Volf; Deborah F Smith
Journal:  PLoS Pathog       Date:  2017-01-17       Impact factor: 6.823

9.  Use of chiral cell shape to ensure highly directional swimming in trypanosomes.

Authors:  Richard John Wheeler
Journal:  PLoS Comput Biol       Date:  2017-01-31       Impact factor: 4.475

Review 10.  Shape, form, function and Leishmania pathogenicity: from textbook descriptions to biological understanding.

Authors:  Jack Sunter; Keith Gull
Journal:  Open Biol       Date:  2017-09       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.